10/09/2025
4:29 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:29 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:29 PM | Titan Pharmaceuticals (Filer)
| Form S-8 POS | |
10/09/2025
4:30 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:30 PM | Titan Pharmaceuticals (Filer)
| Form S-8 POS | |
10/09/2025
4:30 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:30 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:30 PM | Titan Pharmaceuticals (Filer)
| Form S-8 POS | |
10/09/2025
4:20 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/09/2025
4:21 PM | Titan Pharmaceuticals (Filer)
| Form POS AM | |
10/08/2025
7:21 PM | Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TTNP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Titan Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
10/02/2025
7:47 AM | Nasdaq Stock Market LLC (Filed by)
Titan Pharmaceuticals (Subject)
| Form 25-NSE | |
10/01/2025
3:20 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2025
3:05 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2025
11:28 AM | Titan Pharmaceuticals (Filer)
| Form DEFA14A | |
08/14/2025
4:16 PM | Titan Pharmaceuticals (Filer)
| Form DEFA14A | |
07/22/2025
4:04 PM | Titan Pharmaceuticals (Filer)
| Form DEFM14A | |
07/22/2025
4:06 PM | Titan Pharmaceuticals (Filer)
| Form DEFA14A | |
06/18/2025
3:49 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
4:25 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
4:25 PM | Titan Pharmaceuticals (Subject)
| Form 425 | |
06/02/2025
4:20 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
12:50 PM | Loh Gabriel (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2025
3:05 PM | Titan Pharmaceuticals (Filer)
| Form DEF 14A | |
04/22/2025
3:45 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
3:30 PM | Titan Pharmaceuticals (Filer)
| Form PRE 14A | |
04/16/2025
2:49 PM | Jye Chay Weei (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/20/2025
3:30 PM | Titan Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/08/2025
3:05 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:10 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
8:16 AM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
